Update to Clinical Guidelines for Infant Feeding Supports Shared Decision Making: Clarifying Breastfeeding Guidance for People with HIV
January 31, 2023 — HHS HIV clinical practice guidelines now incorporate breastfeeding options for people with HIV on antiretroviral therapy with sustained undetectable viral load (levels of virus in the blood).
NIH Statement on World AIDS Day 2022: By Anthony S. Fauci, M.D. & Maureen M. Goodenow, Ph.D.
In the 34 years since the first observance of World AIDS Day, transformational progress has been made in the global fight against HIV/AIDS, yet challenges remain.
Remembering Dr. Neal Nathanson, Former Director of the NIH Office of AIDS Research
The NIH Office of AIDS Research (OAR) is deeply saddened by the loss of former OAR Director, Neal Nathanson, M.D., on August 11, 2022. The HIV community and larger medical community lost a scientific pioneer and renowned epidemiologist.
White House Publishes Federal Implementation Plan for National HIV/AIDS Strategy
The National HIV/AIDS Strategy Federal Implementation Plan reflects the collaborative work of representatives from 10 federal departments and details more than 380 action items they will implement individually and collaboratively. This plan documents federal agencies’ commitments to programs, policies, research, and other activities needed to meet the Strategy’s goals. These critical activities, which encompass work to be done in fiscal years 2022–2025, will move our indicators of progress in the right directions.
2022 DEBUT Challenge Winners Announced
The National Institutes of Health announced the winners of the 11th annual Design by Biomedical Undergraduate Teams (DEBUT) Challenge with prizes totaling $130,000. NIH and VentureWell named nine winning teams and five honorable mentions that designed technology solutions to unmet health care needs, including a faster and cheaper way of testing for one of the leading causes of death among people with HIV.
NIH OAR statement on the passing of Archbishop Desmond Tutu
The NIH Office of AIDS Research is saddened by the loss of Archbishop Desmond Tutu, South Africa’s Nobel Peace Prize winner, on December 26, 2021. The HIV community and the world lost an exemplary spiritual and human rights leader. Archbishop Tutu tirelessly fought against apartheid in South Africa, denounced HIV/AIDS denialism and discrimination, advocated for HIV prevention—particularly in women, adolescents and young people, and denounced laws that criminalize sexual orientation as inherently wrong.
OAR contributes a statement to the updated NIH Maternal Morbidity and Mortality Web Portal, Maternal Health-Related Efforts of the NIH Institutes, Centers and Offices page.
Over the years, many NIH Institutes, Centers, and Offices have addresses maternal morbidity and mortality (MMM) from their vantage points. OAR recently contributed a statement to NIH’s MMM Web Portal.
NIH Statement on World AIDS Day 2021: By Anthony S. Fauci, M.D. & Maureen M. Goodenow, Ph.D.
Since 1988, World AIDS Day has been an annual call to end the HIV/AIDS pandemic as we remember the many who lost their lives to the disease. Considerable progress has been made since the first World AIDS Day; however, far too many people continue to acquire HIV and die from its related illnesses.
NIH HIV/AIDS Executive Committee FY 2019 Ending the HIV Epidemic in the U.S. (EHE) Report
For 40 years, the United States federal government has saved countless lives by addressing the human immunodeficiency virus (HIV) pandemic. Many important milestones have been achieved on the road to controlling and mitigating HIV. Despite these achievements, rates of new HIV infections in the United States and globally continue to increase in some populations and remain unchanged in others, reflecting inequalities and health disparities by race, ethnicity, sex, gender, age, socioeconomic status, and geography. Understanding and addressing inequalities and health disparities is key to optimizing the outcomes of decades of HIV and AIDS research.
Dr. Maureen M. Goodenow highlights NIH efforts underway to support HIV early career investigators
OAR is developing and implementing a multipronged initiative to increase the cadre of early career, next-generation HIV investigators—including NIH-defined Early Stage Investigators (ESIs) and Early Established Investigators—across disciplines and institutions.
Dr. Maureen M. Goodenow joins the Elizabeth Glaser Pediatric AIDS Foundation to discuss HIV/AIDS research
Dr. Maureen M. Goodenow, Ph.D., Associate Director for AIDS Research and Director, Office of AIDS Research, National Institutes of Health, spoke with the Elizabeth Glaser Pediatric AIDS Foundation about her professional journey and how research can pave the way for an AIDS-free generation.
FY 2022 NIH HIV/AIDS Professional Judgment Budget
For fiscal year (FY) 2022, the NIH HIV/AIDS Professional Judgment Budget requested $775 million in additional funds, a 25-percent increase in the HIV/AIDS research investment. NIH OAR projected that funding at this level would expedite NIH efforts to pursue emerging discoveries in focused areas of HIV pandemic research, enhance the pipelines of novel HIV prevention and treatment products, ensure a diverse pool of HIV investigators, and expand partnerships with stakeholders inside and outside of government to make greater inroads into mitigating inequalities and ending the HIV epidemic in the United States and globally.
OAR HIV/AIDS DEBUT Challenge prize awarded to a Texas A&M team
In the 2021 Design by Biomedical Undergraduate Teams Challenge, OAR awarded $15,000 to a team from Texas A&M that developed a 3D-printed point-of-care device designed for early diagnosis of HIV.
40 Years of Progress: It’s Time to End the HIV Epidemic
On June 5, 2021, the National Institutes of Health (NIH) Office of AIDS Research (OAR) joined colleagues around the world to commemorate the 40th anniversary of the landmark CDC Morbidity and Mortality Weekly Report (MMWR) that first recognized the syndrome of diseases later named AIDS.
National Institutes of Health Office of AIDS Research HIV Stakeholder Outreach and Engagement Report: June 2018 – February 2020
This report describes the stakeholder outreach and engagement activities of the National Institutes of Health (NIH) Office of AIDS Research (OAR) between mid-2018 and early 2020 that helped inform and harmonize the NIH Strategic Plan for HIV and HIV-related Research and overarching NIH HIV/AIDS research priorities for the period FY 2021-2025.
- NIH OAR Offers New HIV/AIDS Prize in 2019 DEBUT Challenge
- Maureen M. Goodenow, Ph.D., joined the HIV in Rural America webinar to discuss The Lancet’s Special Issue on HIV in the United States.
- FY 2021/2025 NIH Strategic Plan for HIV and HIV-Related Research
- World AIDS Day 2020 event – Science and Community: Working Together to Prepare for the Unexpected
- World AIDS Day 2020 Video
- FY 2020 Professional Judgment Budget
- OAR announces its participation in the 2021 DEBUT Challenge
- NIH Statement on World AIDS Day 2020: By Anthony S. Fauci, M.D. & Maureen M. Goodenow, Ph.D.
- Open Session: HIV-related Intersectional Stigma Research Advances & Opportunities
- OAR and the National Institute on Aging Launch Collaboration
- Drs. Goodenow and Fauci Reflect on Need for HIV Vaccine
- Dr. Goodenow Addresses ATN
- NIH’s Dr. Gina Brown on Highlights of Research on Women & HIV from CROI 2018
- Benefits of HIV Research Go Beyond HIV
- International AIDS Society (IAS) Members Meeting and Joep Lange Memorial Lecture (featuring Dr. Maureen Goodenow)
- In Memoriam: Bonnie Mathieson, Ph.D.
This page last reviewed on February 7, 2023